L'Oreal's (LRLCY.PK -0.5%) Lancome USA unit has received an FDA warning about the marketing of...

|About: L'Oreal Co. ADR (LRLCY)|By:, SA News Editor

L'Oreal's (LRLCY.PK -0.5%) Lancome USA unit has received an FDA warning about the marketing of some of its anti-wrinkle products, saying the products are making claims suggesting they are drugs. Several skin care and eye rejuvenator products claim to "boost the activity of genes and stimulate the production of youth proteins" or provide "immediate lifting" to the eye area, which violate federal drug laws.